Mach aus dieser Rolle ein Bewerbungsgespräch — ein Lebenslauf und ein Anschreiben, die genau auf das zugeschnitten sind, was dieser Arbeitgeber sucht.
Rhythm Pharmaceuticals Inc. in Germany is seeking a Hospital Affairs Lead (HAL) to own sales responsibility for our product across approved indications.
You will collaborate with the National and International teams to define sales strategy and act as a trusted commercial partner to external experts and decision makers. The role requires building partnerships with HCPs, payers and multidisciplinary teams, leading an omnichannel approach, and ensuring compliant, data-driven patient care programs
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to learn, adapt, and our tenacity to overcome barriers, together.
As a member of the Rhythm Germany field-based team, you will be working within the field of rare MC4R pathway diseases. As the Hospital Affairs Lead (HAL), you will own sales responsibility for our product in Germany across its approved indications, work collaboratively within the National and International team to lead the sales strategy and serve as a trusted commercial partner to external experts and decision makers through scientific expertise, project management, network formation and service offerings.
This role is field-based in Germany. Candidates applying must be willing and able to travel frequently.
We are a dynamic and growing global team spanning more than a dozen countries. At Rhythm we are dedicated to transforming the lives of patients living with rare melanocortin-4 receptor (MC4R) pathway diseases by rapidly advancing care and precision medicines that address the root cause. Our team is passionate about expanding access to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism.